A natural experiment in Kenya reveals durable immunosuppressive effects of early childhood malaria: a longitudinal cohort study

  1. Bioscience Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  2. Epidemiology and Demography Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
  3. Pwani University, Kilifi, Kenya
  4. Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, United Kingdom
  5. Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, United States
  6. Imperial College London, London, United Kingdom
  7. Kenya Medical Research Institute, Centre for Geographic Medicine Research, Kilifi, Kenya

Peer review process

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews.

Read more about eLife’s peer review process.

Editors

  • Reviewing Editor
    Marcelo Ferreira
    University of São Paulo, São Paulo, Brazil
  • Senior Editor
    Bavesh Kana
    University of the Witwatersrand, Johannesburg, South Africa

Reviewer #1 (Public review):

Summary:

The study shows that childhood malaria can weaken the antibody response to other vaccines and infections. This suggests that early exposure to P. falciparum may have a long-lasting effect on immunity, with implications for vaccine efficacy in endemic areas.

Strengths:

This study stands out for its longitudinal design, the use of robust immunological techniques, and the comparison between areas with different levels of malaria exposure. Its findings reveal that early malaria can weaken the response to childhood vaccines, with important implications for public health in endemic regions.

Weaknesses:

One of the study's main limitations is the lack of functional data confirming the clinical impact of the low antibody levels. Furthermore, although multiple immune responses were measured, other important components, such as cellular immunity, were not assessed. Furthermore, the results may not be generalizable to other regions.

Reviewer #2 (Public review):

Summary:

The authors investigated whether early-life malaria exposure has long-term effects on immune responses to unrelated antigens. They leveraged a natural experiment in coastal Kenya where two adjacent communities (Junju and Ngerenya) experienced divergent malaria transmission patterns after 2004. Using 15 years of longitudinal data from 123 children with weekly malaria surveillance and annual serological sampling, they measured antibody responses to multiple pathogens using a protein microarray technology and ELISA.

Strengths:

(1) Extensive longitudinal data collection with weekly malaria surveillance, enabling precise exposure classification.

(2) Use of a natural experiment design that allows for causal inference about malaria's immunological effects.

(3) Broad panel of antigens tested, demonstrating generalized rather than antigen-specific effects.

(4) Within-cohort analysis in Ngerenya controls for geographic and environmental factors.

(5) Validation of key findings using both serologic microarray and ELISA.

(6) Important public health implications for vaccine strategies in malaria-endemic regions.

Weaknesses:

(1) Lack of participants' characteristics (socio-economic, nutritional, physical).

(2) Somewhat limited sample size (longitudinal analysis of 123 children total), with further subdivision reducing statistical power for some analyses.

(3) Potential confounding by unmeasured socioeconomic, nutritional, or environmental factors between communities.

(4) Lack of ability to determine the direction of the associations found between malaria exposure and other IgG levels to unrelated pathogens.

(5) Despite good longitudinal data, the main analysis was conducted as a cross-sectional analysis at age 10 for many comparisons, which limits the understanding of temporal dynamics.

(6) Statistical analysis is limited to univariable comparisons without consideration for confounders or adjusting for multiple comparisons.

(7) No mechanistic understanding of how early malaria exposure creates lasting immunosuppression.

(8) No understanding of the clinical Implications of the reduced IgG levels observed in the area with high malaria exposure.

Assessment of Claims:

The data appear to support the authors' primary claims, but the strength of the evidence is limited, and the results should be interpreted with caution. Together with the currently available evidence of P. falciparum's impact on the host's immune function, this natural experiment design provides further evidence for a relationship between early malaria exposure and reduced antibody responses. The within-Ngerenya analysis controls for geographic factors and thus enhances the quality of the evidence; however, it still fails to account for the physical, nutritional, and socio-economic factors that may have driven the observed changes. Additionally, the mechanism underlying this effect remains unclear, and the clinical significance of reduced antibody levels is not established.

Impact and Utility:

This work has fundamental implications for understanding vaccine effectiveness in malaria-endemic regions and may contribute to informing vaccination strategies. The findings, if strengthened, would suggest that children in areas of high malaria transmission may require modified immunization approaches. The dataset provides a valuable resource for future studies of malaria's immunological legacy.

Context:

This study builds on prior work showing acute immunosuppressive effects of malaria but uniquely attempts to demonstrate the durability of these effects years after exposure. The natural experiment design addresses limitations of previous observational studies by providing a more controlled comparison.

  1. Howard Hughes Medical Institute
  2. Wellcome Trust
  3. Max-Planck-Gesellschaft
  4. Knut and Alice Wallenberg Foundation